Stocks›ABUS›Earnings

Arbutus Biopharma earnings

When ABUS reports, and what its stock did after each report.

Next report

Expected around early February, going by its own filing history. The company has not announced a date yet.

Who else reports that week: the earnings calendar.

Last report: Nov 10, 2026, 07:31 ET (before the open). The filing on SEC EDGAR ↗

After each report

SEC EDGAR · 1D EOD

Across the last 5 reports we hold closes for, the first close moved a median 2.69% either way. Up 2 of 5.

Moves are only shown for reports where we hold closing prices.

  1. Nov 10, 202607:31 ET · before the open8-K ↗+2.69%1DRevenue $299.0K−43.5% y/yEPS $0.30quarter to Sep 30, 2026
  2. Aug 12, 202607:31 ET · before the open8-K ↗−1.71%1DRevenue $1.01M−90.6% y/yEPS −$0.03quarter to Jun 30, 2026
  3. May 13, 202607:31 ET · before the open8-K ↗0.00%1DRevenue $179.1M+10054.5% y/yEPS $0.87quarter to Mar 31, 2026
  4. Mar 23, 202607:31 ET · before the open8-K ↗+4.25%1DRevenue $1.05M−33.2% y/yquarter to Dec 31, 2025
  5. Nov 13, 202507:31 ET · before the open8-K ↗−5.79%1DRevenue $529.0K−60.5% y/yEPS −$0.04quarter to Sep 30, 2025
  6. Before Sep 2, 2025 we don't hold closing prices, so these reports show the date and what was filed, without a move.
  7. Aug 6, 202507:31 ET · before the open8-K ↗Revenue $10.74M+522.2% y/yEPS $0.01quarter to Jun 30, 2025
  8. May 14, 202507:31 ET · before the open8-K ↗Revenue $1.76M+15.1% y/yEPS −$0.13quarter to Mar 31, 2025
  9. Mar 27, 202507:31 ET · before the open8-K ↗Revenue $1.57M−26.6% y/yquarter to Dec 31, 2024
  10. Jan 13, 202507:31 ET · before the open8-K ↗Revenue $1.57M−26.6% y/yquarter to Dec 31, 2024
  11. Nov 6, 202407:31 ET · before the open8-K ↗Revenue $1.34M−71.3% y/yEPS −$0.10quarter to Sep 30, 2024
  12. Aug 1, 202407:31 ET · before the open8-K ↗Revenue $1.73M−62.9% y/yEPS −$0.11quarter to Jun 30, 2024
  13. May 2, 202407:31 ET · before the open8-K ↗Revenue $1.53M−77.1% y/yEPS −$0.10quarter to Mar 31, 2024
  14. Feb 29, 202407:31 ET · before the open8-K ↗Revenue $2.15M−65.7% y/yquarter to Dec 31, 2023
  15. Jan 8, 202407:31 ET · before the open8-K ↗Revenue $2.15M−65.7% y/yquarter to Dec 31, 2023
  16. Nov 7, 202307:31 ET · before the open8-K ↗Revenue $4.66M−21.7% y/yEPS −$0.12quarter to Sep 30, 2023
  17. Aug 3, 202307:31 ET · before the open8-K ↗Revenue $4.65M−67.3% y/yEPS −$0.10quarter to Jun 30, 2023

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. Prior-session closes only; not a forecast, not advice.

ABUS: stories, the record and filings →